TWiV 1182: Clinical update with Dr. Daniel Griffin

January 11, 2025

In his weekly clinical update, Dr. Griffin discusses how vaccination and vaccine hesitancy affects public health and disease spread in terms of mpox, the first human death from H5N1 in US, why one should not feed their pets raw pet food and the metapneumonia outbreak in China before reviewing the recent statistics on RSV, influenza and SARS-CoV-2 infections, the WasterwaterScan dashboard, where to find PEMGARDA, how nirmatrelvir-ritonavir/Paxlovid reduces adverse outcomes of COVID in patients with kidney disease, provides information for Columbia University Irving Medical Center’s long COVID treatment center, SARS-CoV-2 infection affects skin conditions including shingles and if long antiviral treatment affects long COVID.

Click arrow to play
Download TWiV 1182 (19 MB .mp3, 31 min)
Subscribe (free): Apple Podcasts, RSSemail

Become a patron of TWiV!

Links for this episode

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to daniel@microbe.tv

The post TWiV 1182: Clinical update with Dr. Daniel Griffin first appeared on This Week in Virology.

Leave a Reply

Your email address will not be published. Required fields are marked *

0 comments on “TWiV 1182: Clinical update with Dr. Daniel Griffin

  1. dcpattie Dec 24, 2014

    Another great TWIV – thanks guys. I appreciate Alan’s perspective on influenza vaccination, something I’ve pondered a lot over the past 10-years. I generally agree with Alan’s comments with one exception – the no side effects aspect of influenza vaccination. Just to be clear, I am 100% pro vaccination and what I’m about to discuss is outside the rare known side effects of influenza vaccination (1976- guillain barre and 2009-narcolepsy).

    We now have two peer-reviewed publications showing an increased risk of non-influenza virus infections (other ILI’s) and receiving the influenza vaccination. Although rhinovirus,
    coxsackievirus/echovirus, and adenovirus are generally considered less severe than influenza, don’t tell that to someone with a lingering 3-week adenovirus cough. On a more serious note, these respiratory viruses are responsible for high morbidity and absenteeism around the world. The decision to get vaccinated then becomes even murkier when one considers a poor vaccine-to-virus match.

    So in 2014/15, do I want to receive a vaccination that we now know is ineffective (or at least questionable effectiveness) that may also increase the risk of catching other respiratory illness? For those interested, the publications are open access. 2012 study can be found here: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404712/pdf/cis307.pdf [DOI: 10.1093/cid/cis307], and the 2014 study can be found here: http://onlinelibrary.wiley.com/doi/10.1111/irv.12229/pdf [DOI:10.1111/irv.12229].